Home > Insider Trading > Filing (0001415889-21-004264)

Filing Details

Accession Number:: 0001415889-21-004264
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-07 17:16:33
Reporting Period:: 2021-09-02

Accepted Time:: 2021-09-07 17:16:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1827090	Certara Inc.	CERT	Services-Prepackaged Software (7372)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1834170	R. Craig Rayner	C/O Certara, Inc. 100 Overlook Center, Suite 101 Princeton NJ 08540	President, Integrated Drug Dev	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-09-02	3,900	$33.51	366,572	No	4	S	Direct
Common Stock	Disposition	2021-09-02	1,900	$34.15	364,672	No	4	S	Direct
Common Stock	Disposition	2021-09-02	48,462	$36.64	316,210	No	4	S	Direct
Common Stock	Disposition	2021-09-02	200	$37.21	316,010	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $32.91 to $33.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $34.12 to $34.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $36.19 to $37.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $37.21 to $37.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.